Results 131 to 140 of about 72,546 (336)

Atypical Fibroxanthoma/Pleomorphic Dermal Sarcoma With Osseous Metaplasia: A Series of Three Cases

open access: yesJournal of Cutaneous Pathology, EarlyView.
ABSTRACT Atypical fibroxanthoma (AFX) and pleomorphic dermal sarcoma (PDS) are rare mesenchymal tumors typically arising on sun‐damaged skin of the head and neck in elderly patients. PDS is a more aggressive tumor but with similar demographics, cellular morphology, immunohistochemical features, and genetic findings.
Taylor Novice   +3 more
wiley   +1 more source

Giant cell tumor of the capitate: an unusual case with 10 years follow-up

open access: yesSICOT-J, 2015
Giant cell tumor of the small bones, particularly the carpal bones of the hand, is exceedingly rare. We present a case report of giant cell tumor of the capitate in a 24 year-old female with 10 years postoperative follow-up.
Duman Serda   +4 more
doaj   +1 more source

Rankl expression as a prognostic marker in stage III giant cell tumour of the bone [PDF]

open access: yes, 2015
Introduction: Giant cell tumour of bone is an aggressive benign bone tumor composed of unstable spindle shaped neoplastic mononuclear stromal cells and reactive components osteoclast like giant cells. GCT in Asian population including Malaysia, presented
Abdul Ghani , Nur Sabrina
core  

Digital Pathology in Hematopathology: From Vision to Deployment

open access: yesInternational Journal of Laboratory Hematology, EarlyView.
ABSTRACT Digital pathology (DP) has evolved alongside other technical advances, transforming our daily lives and diagnostic medicine. It is likely that, as in other areas of life, science, and medicine, the overall level of digitization will continue to rise, along with an increasing number of groups implementing DP.
Ryan C. Shean, Anton V. Rets
wiley   +1 more source

Periodontitis and Periodontal Conditions in Systemically Healthy Children and Adolescents

open access: yesJournal of Clinical Periodontology, EarlyView.
ABSTRACT Objective To answer the PICoS question ‘in systemically healthy children and adolescents (Population), what are the main features of periodontitis, necrotising periodontal diseases (NPD) and other periodontal conditions (periodontal abscesses, endo‐periodontal lesions, traumatic occlusal forces, prosthesis‐ and tooth‐related factors ...
Inbar Eshkol‐Yogev   +5 more
wiley   +1 more source

Giant cell tumor of soft tissue in groin region, clinically diagnosed as inguinal lymphadenopathy

open access: yesJournal of Research in Medical Sciences, 2006
Giant cell tumor of soft tissue is a rare primary soft tissue neoplasm with clinical and histological similarities to giant cell tumor of bone. Most cases arise from superficial soft tissue of extremities and present as painless and well circumscribed ...
Ahmad Sobhan Ardakani   +1 more
doaj  

Clinicopathological Conference: Painful Leg Mass in a 23-Year-Old Male [PDF]

open access: yes, 1966
Report based on a clinicopathlogical conference transcript from the Medical College of Virginia regarding a painful leg mass in a 23 year-old male. Discussants include Gerald A.
Gildersleeve, Gerald A., Kay, Saul
core   +1 more source

Deep and disseminated dermatophytosis in immunocompromised populations—A systematic review

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
Dermatophyte infections of the dermis and subcutaneous tissue (i.e. deep dermatophytosis)—associated with secondary complications including pseudomycetoma and systemic dissemination—affect vulnerable populations with primary or acquired immunodeficiencies.
Aditya K. Gupta   +5 more
wiley   +1 more source

MicroRNA-16-5p Inhibits Osteoclastogenesis in Giant Cell Tumor of Bone [PDF]

open access: hybrid, 2017
Shang Sang   +4 more
openalex   +1 more source

The “Reducing Inflammation for Greater Health Trial (RIGHT)” Study—Concept, Rationale, and Design

open access: yesJournal of the American Geriatrics Society, EarlyView.
ABSTRACT The Reducing Inflammation for Greater Health Trial's (RIGHT) study is a single‐center, randomized, double‐blind, placebo‐controlled trial designed to test whether clazkizumab, an interleukin‐6 (IL‐6) inhibitor, can improve or slow decline in physical, cognitive, and vascular function in older adults, when compared to a placebo.
Sebastian E. Sattui   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy